BioAge Labs, Inc
Price
FilingsNewest: 8-K, Other eventsOct 2 →InsidersNo open-market buys. 3 insiders sold $6.2M, all 11 sales on a 10b5-1 plan.→Holdersa16z 7.1%BlackRock 6.2%Cormorant 5.2%→Financing →PeersClosest companies: ALEC, TYRA, ANNX→
From the filings
Figures
- Revenue
- $10.4Mlast 12 months
- Net income
- −$94.5Mlast 12 months
- Operating cash flow
- −$88.3Mlast 12 months
- Cash and equivalents
- $74.0Mat the last balance sheet
- Total debt
- $0.00at the last balance sheet
- Shares outstanding
- 45.8M shareson issue